Related Experiment Video

Updated: Sep 2, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.4K

BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine

James D Phelan1, Thomas Oellerich2,3,4

  • 1Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Cancer Discovery
|August 5, 2022
PubMed

Insights

Mutations in BCL10 protein, a key activator of NF-κB signaling, are common in a diffuse large B-cell lymphoma subtype. This study reveals distinct signaling roles and therapeutic targets for these BCL10 mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The BCL10 protein is a crucial signaling activator downstream of the B-cell receptor pathway.
  • Nearly 40% of the BN2/C1 genetic subtype of diffuse large B-cell lymphoma (DLBCL) exhibit mutations in BCL10.
  • The functional impact of these BCL10 mutations on oncogenic signaling and their therapeutic implications are not well understood.

Discussion:

  • This study investigates the distinct mechanisms by which recurrent BCL10 mutations drive oncogenic signaling in DLBCL.
  • It explores the differential effects of these mutations on NF-κB pathway activation.
  • The research identifies specific therapeutic vulnerabilities associated with different BCL10 mutations.

Key Insights:

  • Recurrent BCL10 mutations in DLBCL exhibit distinct functional mechanisms in regulating oncogenic signaling.
  • Different BCL10 mutations confer varying sensitivities to targeted precision medicine agents.
  • Understanding these mutation-specific effects is critical for developing effective DLBCL therapies.

Outlook:

  • Further research into BCL10 mutation-specific signaling pathways can refine targeted treatment strategies for DLBCL.
  • This work paves the way for personalized medicine approaches in treating DLBCL patients with BCL10 mutations.
  • Identifying novel therapeutic vulnerabilities could lead to improved patient outcomes in DLBCL.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

497

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K